Search Results 1101-1110 of 10266 for total t4
The primary study hypothesis is that pembrolizumab will prolong progression-free survival (PFS) or overall survival (OS) compared to current SOC chemotherapy.
Total bilirubin < 1.5 x upper limit of normal (ULN) (or < 3 x ULN for subjects with Gilbert's syndrome); Creatinine clearance ≥ 50 mL/min on the basis of ...
Patients who did not complete surveys at baseline and 12 months post-transplant as a part of the SIMPLE study. Note: Other protocol defined Inclusion ...
... total hip replacement, Failed total knee replacement, Failed back syndrome. Show more areas of focus for Ryan S. D'Souza, M.D. ...
The overall goals of this study are to evaluate similarities and differences of the known genetic and non-genetic epidemiological factors associated with ...
About this study. To compare Overall Survival (OS) for INT230-6 vs United States (US) Standard of Care (SOC) in participants with unresectable or metastatic ...
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...
... complete resection. Patient Adherence and Symptoms During Post-operative Fluid Restriction Protocol After Transsphenoidal Surgery. Jacksonville, Fla. The ...
... Total Body Irradiation (Cy/TBI) Cyclophosphamide (120 mg/kg) TBI (1200-1420 cGy). • Recovery of counts by day 42 and able to start midostaurin by day 60 post ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.